<p>A, D, The effect of suppression of <i>MSH3</i>, using an inducible shRNA system (doxycycline 1 µg/ml, DOX+), upon chemosensitivity of cell lines to treatment with SN-38 (A) or oxaliplatin (D) [48 h] relative to control cells (DOX-). B,C,E,F, HCT116+3+5 and SW480 cells lines with constitutive knockdown of <i>MSH3</i> by shRNA were treated with SN-38 (B, C) or oxaliplatin (E, F) and clonogenic survival was determined relative to cells with control shRNA. G,H,I, HCT116+3+5 cells with <i>MSH3</i> suppression (DOX+) or gene knockdown using shRNA were treated with 5-FU for 48 h and clonogenic survival was determined compared to control cells (DOX- or non targeted shRNA). Data are presented as mean ± standard errors <i>vs</i> control cells from...
<p>(A) MHCC97H cells were incubated with varying concentrations of PQ401, beginning on 0 day. Prolif...
<p>(<b>A</b>) RT-PCR analysis of hNOXA expression <i>in vitro</i> after transfection of A2780s cells...
<p>(<b>A</b>) Proliferation rate of cells expressing the shRNA targeting FTSJ3. (<b>B</b>) Prolifera...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p><b>(A)</b> Flow cytometry plots showing induction of dsRed and a linked shRNA upon treatment with...
<p>A) QRT-PCR for Drosha in HCT116 WT, and DROSHA shRNA cells, with or without 500 ng/ml of Doxycycl...
<p> <b>h treatment with 5-floururacil, cytosine arabinoside, doxorubicin and cisplatin.</b> SKW-3 ce...
MSH3 is a DNA mismatch repair (MMR) gene that undergoes frequent somatic mutation in colorectal canc...
<p>(<b>A</b>) Clonogenic assay of hMutSα and/or hMutSß proficient cells in response to 5-FU. Cells w...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>(A) Quantification of CDON mRNA was performed after treatment of A549 cells either with 1 µM or 5...
<p>A) Graphic representation of the shRNA sequence (complementary to SSX1 to SSX9) ligated into shRN...
<p>(A) MHCC97H cells were incubated with varying concentrations of PQ401, beginning on 0 day. Prolif...
<p>(<b>A</b>) RT-PCR analysis of hNOXA expression <i>in vitro</i> after transfection of A2780s cells...
<p>(<b>A</b>) Proliferation rate of cells expressing the shRNA targeting FTSJ3. (<b>B</b>) Prolifera...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p><b>(A)</b> Flow cytometry plots showing induction of dsRed and a linked shRNA upon treatment with...
<p>A) QRT-PCR for Drosha in HCT116 WT, and DROSHA shRNA cells, with or without 500 ng/ml of Doxycycl...
<p> <b>h treatment with 5-floururacil, cytosine arabinoside, doxorubicin and cisplatin.</b> SKW-3 ce...
MSH3 is a DNA mismatch repair (MMR) gene that undergoes frequent somatic mutation in colorectal canc...
<p>(<b>A</b>) Clonogenic assay of hMutSα and/or hMutSß proficient cells in response to 5-FU. Cells w...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>(A) Quantification of CDON mRNA was performed after treatment of A549 cells either with 1 µM or 5...
<p>A) Graphic representation of the shRNA sequence (complementary to SSX1 to SSX9) ligated into shRN...
<p>(A) MHCC97H cells were incubated with varying concentrations of PQ401, beginning on 0 day. Prolif...
<p>(<b>A</b>) RT-PCR analysis of hNOXA expression <i>in vitro</i> after transfection of A2780s cells...
<p>(<b>A</b>) Proliferation rate of cells expressing the shRNA targeting FTSJ3. (<b>B</b>) Prolifera...